Captrust Financial Advisors Amicus Therapeutics, Inc. Transaction History

Captrust Financial Advisors

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Aug 16, 2022	SELL	$6.23 - $11.12 $3,351 - $5,982	-538 Reduced 68.45%	248 $3,000
Q1 2022 May 16, 2022	BUY	$7.89 - $12.48 $4,552 - $7,200	577 Added 276.08%	786 $7,000
Q3 2021 Nov 16, 2021	BUY	$8.74 - $11.84 $262 - $355	30 Added 16.76%	209 $2,000
Q2 2021 Aug 16, 2021	SELL	$8.71 - $10.72 $958 - $1,179	-110 Reduced 38.06%	179 $2,000
Q1 2021 May 17, 2021	BUY	$9.2 - $23.86 $2,658 - $6,895	289 New	289 $3,000

311

314M

516K

833K

Ticker FOLD
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 280,497,984
Market Cap $2.53B
Description
Amicus Therapeutics, Inc., a biotechnology company, focuses on discovering, developing, and delivering medicines for rare diseases. Its commercial product and product candidates include Galafold, an oral precision medicine for the treatment of adults with a confirmed diagnosis of Fabry disease and an amenable galactosidase alpha gene variant bas...

Get notified when there are updates to the investment portfolio of Captrust Financial Advisors, based on Form 13F filings with the SEC.

Stay updated on Captrust Financial Advisors with notifications on news.